Global Longlife Hospital and Research Ltd saw a significant shift in its shareholding pattern following an open market acquisition by Abhishek Ashvinbhaj Kamdar HUF. The Hindu Undivided Family (HUF) acquired 5,35,000 equity shares, representing 5.09% of the company’s total voting capital, on September 25, 2026.

This transaction marks the initial holding for the acquirer, as the disclosure indicates a nil position prior to this acquisition. The purchase was executed through the open market segment on the BSE, where the hospital chain’s shares are listed. The acquirer is not part of the promoter or promoter group, classifying this as a substantial acquisition by a non-promoter entity under SEBI regulations.

Acquisition Details

The filing confirms that the total share capital of the target company remained unchanged at 1,05,00,000 equity shares with a face value of ₹10 each, aggregating to ₹10,50,00,000. The diluted share capital also remains identical to the paid-up equity capital, indicating no outstanding convertible instruments that would alter the denominator for percentage calculations.

Regulatory Disclosure

The acquisition triggers disclosures under Regulation 29(1) and Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The threshold for mandatory disclosure was crossed as the holding moved from zero to above 5%. The Karta of the HUF, Abhishek Ashvinbhai Kamdar, signed the declaration from Surat, Gujarat.

What the Numbers Show

The data reveals a clean entry into the shareholder base. Since the pre-acquisition holding was nil, the entire 5.09% stake represents new money entering the register. The absence of encumbrances, warrants, or convertible securities in the post-acquisition column suggests the HUF holds pure equity voting rights without any derivative exposure or pledged collateral associated with these specific shares. This concentration of ownership in a single non-promoter entity could influence future voting dynamics given the relatively small total share count of 1.05 crore.

Global Longlife Hospital and Research promoter Dhruv Sureshkumar Jani has significantly reduced his stake in the company, selling 7,22,000 equity shares through the open market. The transaction, executed between August 10 and August 12, 2026, leaves Jani with a residual holding of just 990 shares, marking a near-complete exit from his previous position.

The sale was disclosed under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Prior to the transaction, Jani held 7,22,990 shares, representing 6.89% of the company’s total voting capital. Following the offloading of 7,22,000 shares, his stake dropped to 0.01%.

Transaction Details

The equity share capital of Global Longlife Hospital and Research Limited remains unchanged at ₹10,50,00,000, comprising 1,05,00,000 equity shares of ₹10 each. There were no warrants, convertible securities, or voting rights acquired or sold otherwise than by shares involved in this transaction.

What the Numbers Show

The transaction represents a near-total divestment by the promoter. With only 990 shares remaining out of a total capital base of 1,05,00,000 shares, Jani’s economic interest in the company is now negligible. The absence of any encumbrances or pledge details in the filing suggests the shares were freely tradable at the time of sale.